MyAverix Finance
US · Healthcare
Regenxbio Inc (RGNX)
Biotechnology
Regenxbio Inc (RGNX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RGNX
Regenxbio Inc (RGNX) — FAQ
What is RGNX's P/E ratio?
The price-to-earnings (P/E) ratio for Regenxbio Inc (RGNX) is 18.00 (data as of 2026-03-24).
Does Regenxbio Inc pay a dividend?
Dividend yield is not available in the current snapshot for Regenxbio Inc (RGNX). Check the MyAverix Finance app for the latest dividend data.
What sector is Regenxbio Inc in?
Regenxbio Inc (RGNX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RGNX listed on?
RGNX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.